Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Foundation for Sickle Cell Disease Research
3858 Sheridan Street, Suite SHollywood, Florida, United States
Email Phone Web
The Foundation for Sickle Cell Disease Research is a comprehensive, non-profit organization that provides a platform for researchers, healthcare providers, and those living with sickle cell disease. Working collaboratively with academia, pharmaceutical, biotechnology and community organizations, the best practices are identified to help with the management and future care for sickle cell patients.
FSCDR was founded by Dr. Lanetta Bronté-Hall in December 2012 after working closely with the sickle cell community and noticing the extreme lack of care for a disease that affects 3 million people nationwide. Dr. Bronté-Hall serves as principal investigator on grants and industry-sponsored trials in sickle cell disease.
As of February 2015, FSCDR opened the Sickle Cell Care and Research Network, the nation’s first standalone outpatient center completely devoted to sickle cell care and services. This is historically significant, as the South Florida community has one of the nation’s highest numbers of individuals affected by sickle cell, but not yet had a center specifically made for sickle cell treatment.
+myBinderRelated Content
-
FDA Awards $2M to Phase 2 Trial of Vitamin D for Reducing Risk of SCD Respiratory ComplicationsThe U.S. Food and Drug Administration (F...
-
Transfusion Practices and Strategies for Individuals With Hemoglobin DisordersIntroduction • Describe the optimal h...
-
The severity of anaemia depletes cerebrovascular dilatory reserve in children with sickle cell disease: a quantitati...Overt ischaemic stroke is one of the mos...
-
Camp Sickle StarsCamp Sickle Stars is the only camp in th...
-
Study Confirms Safe Use of Opioids for Pain Control in Sickle Cell DiseaseThe most common cause of hospital admiss...
-
Children’s Hospital Oakland Research InstituteDuring our first 50 years, Children’s ...
-
Sancilio Pharmaceuticals Company, Inc. (SPCI) Receives Rare Pediatric Disease Designation From the US Food and Drug ...Sancilio Pharmaceuticals Company, Inc. (...
